System and method for assessing pulmonary performance through transthoracic impedance monitoring
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61N-001/39
A61N-001/00
A61B-005/08
A61B-005/05
출원번호
US-0885145
(2004-07-06)
등록번호
US-7329226
(2008-02-12)
발명자
/ 주소
Ni,Quan
Hartley,Jesse W.
Lee,Kent
Stahmann,Jeffrey E.
출원인 / 주소
Cardiac Pacemakers, Inc.
대리인 / 주소
Inouye,Patrick J. S.
인용정보
피인용 횟수 :
43인용 특허 :
132
초록▼
A system and method for assessing pulmonary performance through transthoracic impedance monitoring is described. Transthoracic impedance measures are directly collected through an implantable medical device. The transthoracic impedance measures are correlated to pulmonary functional measures relativ
A system and method for assessing pulmonary performance through transthoracic impedance monitoring is described. Transthoracic impedance measures are directly collected through an implantable medical device. The transthoracic impedance measures are correlated to pulmonary functional measures relative to performance of at least one respiration cycle. The transthoracic impedance measures are grouped into at least one measures set corresponding to one of an inspiratory phase and an expiratory phase. The at least one transthoracic impedance measures set are evaluated to identify a respiratory pattern relative to the inspiratory phase or the expiratory phase to represent pulmonary performance.
대표청구항▼
What is claimed is: 1. A system for assessing pulmonary performance through transthoracic impedance monitoring, comprising: an implantable medical device to directly collect transthoracic impedance measures; a correlation component to correlate the transthoracic impedance measures to pulmonary func
What is claimed is: 1. A system for assessing pulmonary performance through transthoracic impedance monitoring, comprising: an implantable medical device to directly collect transthoracic impedance measures; a correlation component to correlate the transthoracic impedance measures to pulmonary functional measures relative to performance of at least one respiration cycle and to group the transthoracic impedance measures into at least one measures set corresponding to one of an inspiratory phase and an expiratory phase; and an analysis component to evaluate the pulmonary functional measures which were determined from the at least one transthoracic impedance measures set to identify a respiratory pattern relative to the inspiratory phase or the expiratory phase to represent pulmonary performance, comprising: a trending subcomponent to evaluate a trend in changes in the respiratory pattern relative to at least one previous respiratory pattern; a monitoring subcomponent to monitor the trend and the changes; and an alert subcomponent to compare the trends to thresholds and to generate an alert upon sufficient deviation from the thresholds. 2. A system according to claim 1, wherein the at least one respiration cycle comprises a forced expiration. 3. A system according to claim 2, wherein the pulmonary functional measures comprise at least one of volumetric, rate and derived measures. 4. A system according to claim 3, wherein the pulmonary functional measures further comprise at least one of respiration rate, tidal volume and minute ventilation. 5. A system according to claim 2, further comprising: a set of sensors to measure forced vital capacity and forced expiratory volume by respectively measuring a total volume exhaled during performance of the forced expiration and a volume expired during a tracked time period. 6. A system according to claim 5, wherein the forced vital capacity and the forced expiratory volume are analyzed to characterize one of an obstructive respiratory pattern and a restrictive respiratory pattern. 7. A system according to claim 2, further comprising: a set of sensors to measure a forced expiratory flow by identifying a middle volume of the forced expiration and tracking a duration of the forced expiration. 8. A system according to claim 2, further comprising: a derivation subcomponent to derive at least one of a ratio of forced expiratory volume to forced vital capacity and a maximal midexpiratory flow rate. 9. A system according to claim 8, further comprising: a comparison subcomponent to respectively compare the at least one of the forced expiratory volume to forced vital capacity ratio and the maximal midexpiratory flow rate to predicted values of the forced expiratory volume to forced vital capacity ratio and the maximal midexpiratory flow rate. 10. A system according to claim 2, wherein the implantable medical device is calibrated and a baseline set of transthoracic impedance measures is established. 11. A system according to claim 2, further comprising: a reference electrode and a sensor to measure blood pH through the implantable medical device; and control circuitry to determine pH information from the measured blood pH. 12. A system according to claim 2, wherein the implantable medical device comprises at least one of an implantable cardiac pacemaker, an implantable cardioverter defibrillator, an implantable cardiac resynchronization device, an implantable cardiovascular monitor, and a therapeutic device that monitors and treats structural problems of the heart. 13. A system according to claim 2, further comprising: a communication subcomponent to communicate the pulmonary performance through at least one of an implantable medical device and a non-implantable medical device. 14. A system according to claim 2, further comprising: a sensor to measure oxygen saturation through the implantable medical device; and control circuitry to determine blood gases from the measured oxygen saturation. 15. A method for assessing pulmonary performance through transthoracic impedance monitoring, comprising: directly collecting transthoracic impedance measures through an implantable medical device; correlating the transthoracic impedance measures to pulmonary functional measures relative to performance of at least one respiration cycle; grouping the transthoracic impedance measures into at least one measures set corresponding to one of an inspiratory phase and an expiratory phase; and evaluating the pulmonary functional measures which were determined from the at least one transthoracic impedance measures set to identify a respiratory pattern relative to the inspiratory phase or the expiratory phase to represent pulmonary performance, comprising: evaluating a trend in changes in the respiratory pattern relative to at least one previous respiratory pattern; monitoring the trend and the changes; comparing the trends to thresholds; and generating an alert upon sufficient deviation from the thresholds. 16. A method according to claim 15, wherein the at least one respiration cycle comprises a forced expiration. 17. A method according to claim 16, further comprising: measuring oxygen saturation through the implantable medical device; and determining blood gases from the measured oxygen saturation. 18. A method according to claim 16, further comprising: measuring arterial pH through the implantable medical device; and determining pH information from the measured arterial pH. 19. A method according to claim 16, wherein the pulmonary functional measures comprise at least one of volumetric, rate and derived measures. 20. A method according to claim 19, wherein the pulmonary functional measures further comprise at least one of respiration rate, tidal volume and minute ventilation. 21. A method according to claim 16, further comprising performing at least one of an implantable cardiac pacemaker therapy, an implantable cardioverter defibrillator therapy, an implantable cardiac resynchronization therapy, an implantable cardiovascular monitoring, and a therapeutic device that monitors and treats structural problems of the heart. 22. A method according to claim 16, further comprising: measuring forced vital capacity and forced expiratory volume by respectively measuring a total volume exhaled during performance of the forced expiration and a volume expired during a tracked time period. 23. A method according to claim 22, further comprising: analyzing the forced vital capacity and the forced expiratory volume characterizing one of an obstructive respiratory pattern and a restrictive respiratory pattern. 24. A method according to claim 16, further comprising: measuring a forced expiratory flow by identifying a middle volume of the forced expiration and tracking a duration of the forced expiration. 25. A method according to claim 16, further comprising: deriving at least one of a ratio of forced expiratory volume to forced vital capacity and a maximal midexpiratory flow rate. 26. A method according to claim 25, further comprising: respectively comparing the at least one of the forced expiratory volume to forced vital capacity ratio and the maximal midexpiratory flow rate to predicted values of the forced expiratory volume to forced vital capacity ratio and the maximal midexpiratory flow rate. 27. A method according to claim 16, further comprising: calibrating the implantable medical device; and establishing a baseline set of transthoracic impedance measures. 28. A method according to claim 16, further comprising: communicating the pulmonary performance through at least one of an implantable medical device and a non-implantable medical device. 29. An apparatus for assessing pulmonary performance through transthoracic impedance monitoring, comprising: means for directly collecting transthoracic impedance measures through an implantable medical device; means for correlating the transthoracic impedance measures to pulmonary functional measures relative to performance of at least one respiration cycle; means for grouping the transthoracic impedance measures into at least one measures set corresponding to one of an inspiratory phase and an expiratory phase; and means for evaluating the pulmonary functional measures which were determined from the at least one transthoracic impedance measures set to identify a respiratory pattern relative to the inspiratory phase or the expiratory phase to represent pulmonary performance, comprising: means for evaluating a trend in changes in the respiratory pattern relative to at least one previous respiratory pattern; means for monitoring the trend and the changes; means for comparing the trends to thresholds; and means for generating an alert upon sufficient deviation from the thresholds.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (132)
Funke Hermann D. (Bonn DEX), Acoustic body bus medical device communication system.
Reinhold ; Jr. Herbert E. (Rockville MD) Auerbach Albert A. (New York NY), Ambulatory monitoring system with real time analysis and telephone transmission.
Greenhut Saul E. (Aurora CO) Murphy Anthony (Annandale AUX), Apparatus and method for detection of atrial fibrillation by ventricular stability and ventricular pacing.
Cosentino Louis C. ; Duea Michael John ; Duea Duane Robert ; Dorfe Steven George ; Nubson Richard C. ; Cosentino Judith A., Apparatus and method for monitoring and communicating wellness parameters of ambulatory patients.
Abrams Philip S. (McLean VA) Behar Al (Reston VA) Behar Orna (Reston VA) Brenneman Scott A. (Falls Church VA) Frederiksen Lee W. (McLean VA) Ide Nicholas C. (College Park MD) Jerome Albert (Herndon V, Apparatus to control diet and weight using human behavior modification techniques.
Alt Eckhard (Eichendorffstrasse 52 8012 Ottobrunn DEX), Cardiac and pulmonary physiological analysis via intracardiac measurements with a single sensor.
Salo Rodney W. (Fridley MN) Spinelli Julio C. (Shoreview MN) Tockman Bruce A. (Minneapolis MN), Cardiac stimulating apparatus and method for heart failure therapy.
Dempsey Michael K. (Acton MA) Kotfila Mark S. (Chelmsford MA) Snyder Robert J. (Westford MA), Flexible patient monitoring system featuring a multiport transmitter.
Braun Jeffrey C. ; Jacobus Charles J. ; Booth Scott ; Suarez Michael ; Smith Derek ; Hartnagle Jeff ; Leprell Glenn, General-purpose medical instrumentation.
Todd D. Alleckson ; Energy Cruse, II ; Karyn Grant ; Robert C. Leichner ; Gaurang C. Mehta ; James M. Rueter ; Thomas A. Shoup ; Alexander L. Tudor ; Ronald T. Yamada, Home hub for reporting patient health parameters.
Combs William J. ; Condie Catherine R. ; Martin Roy ; Warkentin Dwight H. ; Wahlstrandl John D., Impedance monitor for discerning edema through evaluation of respiratory rate.
Nappholz Tibor A. (Englewood CO) Hursta William N. (Littleton CO) Dawson Albert K. (Denver CO) Steinhaus Bruce M. (Parker CO), Implantable ambulatory electrocardiogram monitor.
Larson ; Jr. Carl O. ; Smith James S. ; Chapman John H. ; Slimon Scot A. ; Trahan John D. ; Brozek Robert J. ; Franco Alberto ; McGarvey John J. ; Rosen Marvin E. ; Pasque Michael K., Implantable device monitoring arrangement and method.
Obel Israel W. P. (Johannesburg ZAX) Bourgeois Ivan (Verviers BEX), Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload.
Combs, William J.; Condie, Catherine R.; Martin, Roy; Warkentin, Dwight H.; Wahlstrand, John D.; Thompson, David L.; Wang, Li, Implantable medical device for measuring time varying physiologic conditions especially edema and for responding thereto.
Chiang Chih-Ming J. (Highlands Ranch CO) Bernstein Alan D. (Montvale NJ) Parsonnet Victor (Millburn NJ) Nappholz Tibor (Englewood CO), Interactive probability based expert system for diagnosis of pacemaker related cardiac problems.
Causey ; III James D. (Simi Valley CA) Schloss Harold C. (Los Angeles CA) Snell Jeffery D. (Northridge CA), Interactive programming and diagnostic system for use with implantable pacemaker.
Whayne James G. ; Panescu Dorin ; McGee David ; Dupree Daniel A. ; Swanson David K. ; Nguyen Tuan, Interface for performing a diagnostic or therapeutic procedure on heart tissue with an electrode structure.
David L. Thompson ; Steven D. Goedeke, Medical management system integrated programming apparatus for communication with an implantable medical device.
Louis C. Cosentino ; Michael John Duea ; Duane Robert Duea ; Steven George Dorfe ; Daniel L. Cosentino, Medical wellness parameters management system, apparatus and method.
Stutman Peter S. (Sudbury MA) Miller J. Mark (Belmont MA), Method and apparatus for alerting patients and medical personnel of emergency medical situations.
Joo Tae H. ; Hampton David R. ; Schmitt Paul W. ; Medema Douglas K. ; Niskanen Robert A., Method and apparatus for detecting a condition associated with acute cardiac ischemia.
Finkelstein Stanley M. (St. Louis Park MN) Cohn Jay N. (Minneapolis MN), Method and apparatus for monitoring and diagnosing hypertension and congestive heart failure.
Seare Jerry G. (Salt Lake City UT) Smith-Wilson Patricia A. (North Salt Lake UT) VanWagoner Kurt (Layton UT) Mattey Jean A. (Midvale UT) Snyder Eileen K. (Sandy UT) Wahlstrom Candace C. (Salt Lake Ci, Method and system for generating statistically-based medical provider utilization profiles.
Klein George J.,CAX ; Warkentin Dwight H. ; Riff Kenneth M. ; Lee Brian B. ; Carney James K. ; Turi Gregg ; Varrichio Anthony J., Minimally invasive implantable device for monitoring physiologic events.
Snyder Leon T. (Boca Raton FL) Scarfone Frank A. (Boca Raton FL) Reuss James L. (Boca Raton FL) Campen George V. (Fort Lauderdale FL) Yates George H. (Boca Raton FL), Multi-channel ventilation monitor and method.
Wright Gregory John ; Hochberg Philip Scott ; Bellusci Darcy B. ; Brinster Eric Gregory ; Brinton Mark Willard ; Folkerts Sue R. ; Foster Brian Timothy ; King Anthony Edward ; Maloney Kevin Patrick ;, Open architecture cardiology information system.
Harpal S. Kumar GB; Paul Johnson GB; Michael D. Llewellyn GB; William J. Mullarkey GB; William New, Jr. ; Laurence J. Nicolson GB; William G. O'Brien GB; John D. Place GB; Peter M. Relph GB, Portable remote patient telemonitoring system.
Mann Brian M. ; Endaya Melinda ; Levine Paul A., Programmer system and associated methods for rapidly evaluating and programming an implanted cardiac device.
Jesse W. Hartley ; Marc H. Cohen ; Nicholas J. Stessman ; Scott A. Reedstrom ; Steven D. Check ; James P. Nelson, Rate adaptive cardiac rhythm management device using transthoracic impedance.
Langen Pauline A. (Simsbury CT) Katz Jeffrey S. (West Hartford CT) Dempsey Gayle (Needham MA) Pompano James (East Haven CT), Remote monitoring of high-risk patients using artificial intelligence.
Kremer Mark ; Tran Quoc Tai ; Depledge Michael ; Mukhopadhyay Santanu ; Keese William M. ; Arbab-Dehkordi Behrouz, System and apparatus for storage retrieval and analysis of relational and non-relational data.
Surwit Richard S. ; Allen ; III Lyle M. ; Cummings Sandra E., Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients.
Duffin Edwin G. ; Thompson David L. ; Goedeke Steven D. ; Haubrich Gregory J., World wide patient location and data telemetry system for implantable medical devices.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.